EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Oxidized Low-Density Lipoprotein as an Emerging Biomarker in Atherosclerosis: Synthesis and Clinical Implications in Cardiovascular and Metabolic Diseases

Hivre Manjusha, Shrirang Holkar, Deepali Vaishnav

Next Gen Multidisciplinary Research · 30.12.2025 · 1 (2) · 7-16

DOI: 10.66132/mr010202 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Next Gen Multidisciplinary Research, online erschienen am 30.12.2025. Verfasst von Hivre Manjusha und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oxidative modification of low-density lipoprotein is a key process in the onset and development of atherosclerosis and associated cardiometabolic diseases. Unlike LDL cholesterol, oxidized low-density lipoprotein (OxLDL) is a biologically active mediator that induces endothelial dysfunction, foam cell formation, chronic vascular inflammation, plaque progression and plaque destabilization. This review synthesizes the current knowledge on the molecular biology of oxLDL, the molecular pathways controlling formation of oxLDL, and multiple pathogenic effects of oxLDL on the vascular wall. We critically analyse current methods for the measurement of oxLDL, emphasizing their analytical strengths, limitations and problems associated with assay standardization. The clinical significance of oxLDL is reviewed in relation to major disease conditions, such as coronary artery disease, acute coronary syndromes, diabetes mellitus, metabolic syndrome, chronic kidney disease, hypertension, non-alcoholic fatty liver disease, stroke and peripheral arterial disease. Accumulating evidence shows that oxLDL is a source of prognostic information in addition to conventional lipid parameters and improves the cardiovascular risk stratification. Although there are still limits on routine clinical implementation, further improvements in assay technology and increasing mechanistic insight make oxLDL a promising next-generation biomarker for personalised cardiovascular prevention and therapeutic monitoring.

Zitieren

APA

Manjusha, H., Holkar, S., & Vaishnav, D. (2025). Oxidized Low-Density Lipoprotein as an Emerging Biomarker in Atherosclerosis: Synthesis and Clinical Implications in Cardiovascular and Metabolic Diseases. Next Gen Multidisciplinary Research, 1(2), 7-16. https://doi.org/10.66132/mr010202

Vancouver

Manjusha H, Holkar S, Vaishnav D. Oxidized Low-Density Lipoprotein as an Emerging Biomarker in Atherosclerosis: Synthesis and Clinical Implications in Cardiovascular and Metabolic Diseases. Next Gen Multidisciplinary Research. 2025;1(2):7-16. doi:10.66132/mr010202

BibTeX
@article{Manjusha2025,
  author = {Manjusha, Hivre and Holkar, Shrirang and Vaishnav, Deepali},
  title = {Oxidized Low-Density Lipoprotein as an Emerging Biomarker in Atherosclerosis: Synthesis and Clinical Implications in Cardiovascular and Metabolic Diseases},
  journal = {Next Gen Multidisciplinary Research},
  year = {2025},
  volume = {1},
  number = {2},
  pages = {7--16},
  doi = {10.66132/mr010202}
}
Kostenlos starten →